ELIXF (Elixxer) Common Stock: $38.74 Mil (As of Dec. 2025)


What is Elixxer Common Stock?

Elixxer ELIXF Common Stock is $38.74 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Elixxer's quarterly common stock declined from Jun. 2025 ($39.10 Mil) to Sep. 2025 ($38.63 Mil) but then increased from Sep. 2025 ($38.63 Mil) to Dec. 2025 ($38.74 Mil).

Elixxer's annual common stock declined from Dec. 2023 ($39.84 Mil) to Dec. 2024 ($37.51 Mil) but then increased from Dec. 2024 ($37.51 Mil) to Dec. 2025 ($38.74 Mil).

Elixxer Common Stock Historical Data

* Premium members only.

The historical data trend for Elixxer's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer Common Stock Chart

Elixxer Annual Data
Trend Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.61 39.34 39.84 37.51 38.74

Elixxer Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.51 37.23 39.10 38.63 38.74

Elixxer Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $38.74 Mil mean?
Elixxer (ELIXF) has a Common Stock of $38.74 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Elixxer and its competitors.
Is Elixxer's Common Stock too high?
Elixxer's current Common Stock is $38.74 Mil.
How does Elixxer's Common Stock compare to ZTS and UTHR?
Elixxer's Common Stock of $38.74 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Elixxer and its competitors. Elixxer's current Common Stock is $38.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixxer stock overvalued right now?
Elixxer (ELIXF) has a current Common Stock of $38.74 Mil. The current Common Stock is $38.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Elixxer (ELIXF), the current Common Stock is $38.74 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixxer Business Description

Other Exchanges ELXR.H:Canada
Address 200 Bay Street, Suite 3240, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.